Revenue, 2025

USD 4.85 Billion

Forecast, 2035

USD 8.3 Billion

CAGR, 2026-2035

5.52%

Report Coverage

Global

Positive Airway Pressure Devices Market Trends for 2026

The global positive airway pressure devices market size was estimated at USD 4.85 billion in 2025 and is predicted to increase from USD 5.12 billion in 2026 to approximately USD 8.3 billion by 2035, expanding at a CAGR of 5.52% from 2026 to 2035.

The growing respiratory disease burden is increasing the demand for positive airway pressure devices (PAP), leading to new launches. Additionally, growing health awareness, home-based care, and technological advancements are also enhancing the market growth.

Key Takeaways

• Positive airway pressure devices market to crossed USD 5.12 billion by 2026.
• Market projected at USD 8.3 billion by 2035.
• CAGR of 5.52% expected in between 2026 to 2035.
• North America held the major revenue share in the global positive airway pressure devices market in 2025.
• Asia Pacific is expected to be the fastest-growing region between 2026 and 2035.
• By product type, the CPAP segment dominated the market in 2025.
• By product type, the Bi-PAP segment is expected to be the fastest growing during the forecast period.
• By application type, the obstructive sleep apnea segment held a dominant position in the market in 2025.
• By application type, the COPD segment is expected to be the fastest growing during the forecast period.
• By end use, the hospitals & clinics segment held a dominant revenue share of the market in 2025.
• By end use, the home care settings segment is expected to be the fastest growing during the forecast period.

What are the Positive Airway Pressure Devices?

The positive airway pressure devices market is driven by the growing incidence of obstructive sleep apnea and COPD. The positive airway pressure devices encompass the medical devices responsible for the treatment of breathing disorders by delivering pressurized air via mask or nasal interfaces, opening the patient's airways. These devices help in the management and treatment of sleep and respiratory disorders by improving oxygenation and minimizing breathing efforts.

What is the Role of AI in the Market?

AI plays an important role in the positive airway pressure devices market, driving the development of personalized and smart PAP devices by auto-adjusting them in response to the real-time airways obstruction. It identifies breathing patterns, anomalies, mask leaks, etc, offering early detection of diseases and device defects. It also helps in the analysis of larger datasets, optimization of therapy protocols, device design, and pressure algorithms, promoting the development of advanced PAP devices.

What are the Trends & Future Outlook of the Market?

Expanding Home Healthcare

The growing health awareness, increasing geriatric population, and expanding digital healthcare platforms are increasing the adoption of positive airway pressure devices for remote patient monitoring and enhancing PAP device adherence.

Increasing Respiratory Diseases

The growing incidence of respiratory diseases like asthma and chronic obstructive pulmonary disease is increasing the demand for positive airway pressure devices to enhance oxygenation, reduce breathing difficulties, and promote their effective management.

Blooming Technological Innovations

A rise in technological advancements is driving the development of new, smaller, portable designs, with quieter motors, wireless connectivity, auto-adjusting pressure systems, and cloud-based monitoring.

Key Indicators and Highlights

Segmental Insights

By Product Insights

Why Did the CPAP Segment Dominate in the Market in 2025?

The CPAP segment registered its dominance over the global positive airway pressure devices market in 2025, as they are considered the first-line treatment for obstructive sleep apnea. Their simple technology, easy operation, and high effectiveness also increased their use, where their affordability also promoted their acceptance rates.

Bi-PAP

The Bi-PAP segment is expected to show the highest growth during the predicted time, driven by its two-pressure level, offering higher pressure for inhalation while lower for exhalation, improving the patient’s breathing patterns. This increases patient comfort and compliance, driving their use in the treatment of severe respiratory conditions.

By Application Insights

Which Application Type Segment Held the Dominating Share of the Market in 2025?

The obstructive sleep apnea segment held the dominating share of the positive airway pressure devices market in 2025, due to growth in their incidence rates. This increased the use of positive airway pressure devices as the primary treatment option, where the growth in health awareness also increased their adoption rates.

COPD

The COPD segment is expected to grow with the highest CAGR during the upcoming years, due to growing COPD cases driven by increasing air pollution and smoking. The growing demand for non-invasive ventilation and remote patient care trends for COPD management are also increasing the use of positive airway pressure devices.

By End Use Insights

What Made Hospitals & Clinics the Dominant Segment in the Market in 2025?

The hospitals & clinics segment contributed the biggest revenue share of the positive airway pressure devices market in 2025, driven by the presence of skilled personnel and enhanced access to critical care services. This increased the effective use of positive airway pressure devices for the treatment of various respiratory conditions.

Home Care Settings

The home care settings segment is expected to show the fastest growth rate during the predicted time, due to growing demand for home-based treatment. This, in turn, is increasing the use of affordable positive airway pressure devices, enhancing patient comfort and convenience, and driving the development of new user-friendly, portable PAP devices.

Regional Insights

Advanced Healthcare Drives North America

North America dominated the positive airway pressure devices market in 2025, due to the presence of a well-developed healthcare infrastructure, which promoted the early adoption of positive airway pressure devices for the treatment of sleep apnea and respiratory conditions. The growth in health awareness and health care investments also contributed to the market growth.

U.S. Market Trends

The growth in the sleep apnea cases and patient awareness is increasing the demand for positive airway pressure devices in the U.S. The presence of advanced healthcare infrastructures, along with insurance coverage are increasing their accessibility, where technological advancements are also accelerating their innovations.

Growing Respiratory Diseases Boost the Asia Pacific

Asia Pacific is expected to host the fastest-growing positive airway pressure devices market during the forecast period, due to growing respiratory conditions and expanding healthcare, which is increasing the adoption of positive airway pressure devices. Increasing government initiatives, disease screening programs, and technological innovations are also enhancing the market growth.

China Market Trends

The rapid expansion of the healthcare sector across China is increasing the adoption of positive airway pressure devices for the treatment of growing respiratory disorders. The growing advancements in home care services are also increasing their use, encouraging the development of portable and user-friendly PAP devices.

Europe Driven by Well-Established Healthcare Systems

Europe is expected to grow significantly in the positive airway pressure devices market during the forecast period, due to the presence of well-established healthcare systems, which are increasing the availability of positive airway pressure devices. A rise in sleep disorders, health awareness, government initiatives, and R&D activities is also promoting the market growth.

The growing incidence of sleep disorders is increasing the use of positive airway pressure devices to improve breathing patterns. Additionally, the growing health awareness is also increasing the early detection of various respiratory disease increasing their use, where the presence of reimbursement policies is also attracting patients.  

Market Value Chain Analysis

R&D

• The R&D of the positive airway pressure devices focuses on the integration of AI-driven diagnostic algorithms, silent micro-blower technology, and cloud-based remote algorithms.
• Key players: ResMed Inc., Fisher & Paykel Healthcare, and Lowenstein Medical.

Clinical Trials and Regulatory Approvals

• The safety, pressure accuracy, apnea-hypopnea index reduction, and subjective patient comfort are evaluated in the clinical trials and regulatory approvals of the positive airway pressure devices.
• Key players: ResMed Inc., Fisher & Paykel Healthcare, Koninklijke Philips N.V.

Packaging and Serialization

• The packaging and serialization of the positive airway pressure devices involve the use of tamper-evident packaging and unique device identification (UDI) via GS1-compliant 2D data matrix codes for real-time tracking and authentication of each unit.
• Key players: ResMed Inc., Fisher & Paykel Healthcare, Koninklijke Philips N.V.

Patient Support and Services

• The patient-facing mobile apps, automated supply replenishment services, and telehealth coaching are provided in the patient support and services of the positive airway pressure devices.
• Key players: ResMed Inc., React Health, Koninklijke Philips N.V.

Top Vendors and Their Offerings

SWOT Analysis

Strengths

• The positive airway pressure devices provide constant air pressure, which is increasing their use to improve breathing difficulties.
• They also help in preventing airway collapse during sleep or respiratory problems, increasing their adoption rates.
• Their non-invasive approach is also increasing their adoption rates.
• They also help in enhancing oxygenation, which promotes their use in various respiratory diseases.

Weaknesses

• Skin irritation and air leakage from the marks act as the major weakness in the positive airway pressure devices market, limiting their use.
• Poor patient compliance due to increased discomfort from wearing the mask during sleep also reduces their acceptance rates.

Opportunities

• The growing incidence of sleep disorders is increasing the adoption of positive airway pressure devices.
• Similarly, a growing geriatric population and diseases like COPD and asthma are also increasing their demand.
• Increasing health awareness is also driving their adoption across home settings.
• The expanding technology advancements are also promoting their innovations.

Threats

• High cost associated with the manufacturing and quality control of the positive airway pressure devices makes them expensive, limiting their adoption rates.
• Rapid technological changes and intense competition also restrict their advancements.

Recent Developments in the Market

• In January 2026, the F&P Nova Nasal mask, a nasal positive airway pressure (PAP) mask for the treatment of obstructive sleep apnea, was launched by Fisher & Paykel Healthcare in the U.S.
• In December 2025, the Kricket PAP device, a new positive airway pressure device used for the treatment of obstructive sleep apnea, was announced to have received U.S. FDA 510(k) clearance for its use across hospitals, sleep centers, and home settings.

Segments Covered in the Report

By Product

• CPAP
  • Connected
    • Bluetooth-Connected CPAP
    • Wi-Fi & Cellular Connected CPAP
    • Hybrid-Connected
  • Non-Connected
• APAP
• Bi-PAP

By Application

• Obstructive Sleep Apnea
• Respiratory Failures
• COPD

By End Use

• Home Care Settings
• Hospitals & Clinics
• Others (Long-Term Care Facilities, etc.)

By Region

• North America
  • U.S.
  • Canada 
  • Mexico 
  • Rest of North America
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Europe 
  • Western Europe 
    • Germany 
    • Italy
    • France
    • Netherlands
    • Spain
    • Portugal 
    • Belgium
    • Ireland
    • UK 
    • Iceland 
    • Switzerland
    • Poland
    • Rest of Western Europe
  • Eastern Europe 
    • Austria
    • Russia & Belarus 
    • Türkiye
    • Albania 
    • Rest of Eastern Europe 
• Asia Pacific
  • China 
  • Taiwan
  • India 
  • Japan 
  • Australia and New Zealand
  • ASEAN Countries (Singapore, Malaysia)
  • South Korea 
  • Rest of APAC 
• MEA 
  • GCC Countries
    • Saudi Arabia 
    • United Arab Emirates (UAE)
    • Qatar 
    • Kuwait 
    • Oman 
    • Bahrain 
  • South Africa
  • Egypt 
  • Rest of MEA